Skip to main content

Malaria Prevention

  • Chapter
  • First Online:
Manual of Travel Medicine

Abstract

Malaria, a potentially life-threatening parasitic infection transmitted by mosquitoes, continues to be a major global health problem. Malaria remains the most common cause of fever in returned travellers, with an estimated 10,000 cases of travel-associated malaria occuring globally every year. Young children, pregnant women and asplenic individuals are particularly vulnerable to severe malaria, and malaria acquisition is more common among visiting friends and relatives (VFR) travellers, long-term travellers and expatriates. In this chapter, we discuss the global epidemiology of malaria and preventive measures that can be employed to reduce the risk of malaria acquisition by travellers. We include detail on the drugs available for malaria chemoprophylaxis and the different preventive strategies that can be employed, and we provide advice on how to choose the appropriate strategy and drug for the individual traveller.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Key Reading

  • American Academy of Pediatrics. Follow safety precautions when using DEET on children. <www.aap.org/family/wnv-jun03.htm> updated June 2003. Accessed May 2011.

  • Antibiotic Writing Group. Therapeutic guidelines: antibiotic. 15th ed. Melbourne: Therapeutic Guidelines Ltd; 2014.

    Google Scholar 

  • Baird JK. Tafenoquine for travelers’ malaria: evidence, rationale and recommendations. J Travel Med. 2018;25(1):1–13.

    Article  Google Scholar 

  • Baird JK, Lacy MD, Basri H, Barcus MJ, et al. Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. Clin Infect Dis. 2001;33:1990–7.

    Article  CAS  Google Scholar 

  • Bannister B, Hatz C, Toovey S, Price R, Zuckerman JN. The role of standby emergency medication for falciparum malaria: current opinion. Trav Med Infect Dis March. 2004;2:119–26.

    Article  Google Scholar 

  • Berman J. Toxicity of commonly-used antimalarial drugs. Travel Med Infect Dis. 2004;2:171–84.

    Article  Google Scholar 

  • Boubaker R, Herard Fossati A, Meige P, Mialet C, Ngarambe Buffat C, Rochat J, et al. Malaria prevention strategies and recommendations, from chemoprophylaxis to stand-by emergency treatment: a 10-year prospective study in a Swiss Travel Clinic. J Travel Med. 2017;24(5)

    Google Scholar 

  • Centers for Disease Control and Prevention (CDC). Travelers’ Health Yellow Book. <wwwnc.cdc.gov/travel/yellowbook/2018/chapter-3-infections-diseases-related-to-travel/malaria.htm>.

  • Chen LH, Wilson ME, Schlagenhauf P. Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA. 2007;297:2251–63.

    Article  CAS  Google Scholar 

  • Chiodini P, Patel D, Whitty C. Lalloo D on behalf of the Public Health England Advisory Committee for Malaria Prevention for UK Travellers (ACMP). Guidelines for malaria prevention in travellers from the United Kingdom 2017. London: Public Health England; 2017. https://www.gov.uk/government/publications/malaria-prevention-guidelines-for-travellers-from-the-uk. Accessed 6 Aug 2018.

    Google Scholar 

  • Chu CS, Freedman DO. Tafenoquine and G6PD: a primer for clinicians. J Travel Med. 2019;26(4).

    Google Scholar 

  • Croft AM. Malaria: prevention in travelers (non-drug interventions). BMJ Clin Evid. 2014;11:903.

    Google Scholar 

  • Deye GA, Miller RS, Miller L, Salas CJ, Tosh D, Macareo L, et al. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model. Clin Infect Dis. 2012;54(2):232–9.

    Article  Google Scholar 

  • Dow GS, Liu J, Lin G, Hetzell B, Thieling S, McCarthy WF, et al. Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries. Malar J. 2015;14:473.

    Article  Google Scholar 

  • Dow GS, McCarthy WF, Reid M, Smith B, Tang D, Shanks GD. A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area. Malar J. 2014;13:49.

    Article  Google Scholar 

  • Elliott JH, O’Brien D, Leder K, Kitchener S, et al. Imported Plasmodium vivax malaria: demographic and clinical features in non-immune travelers. J Travel Med. 2004;11:213–9.

    Article  Google Scholar 

  • Freedman DO. Malaria prevention in short-term travelers. New Engl J Med. 2008;359:603–12.

    Article  CAS  Google Scholar 

  • Gaillard T, Madamet M, Pradines B. Tetracyclines in malaria. Malar J. 2015;14:445.

    Article  Google Scholar 

  • Genton B, D’Acremont V. Malaria prevention in travelers. Infect Dis Clin North Am. 2012;26(3):637–54.

    Article  Google Scholar 

  • Goodyer LI, Croft AM, Frances SP, Hill N, Moore SJ, Onyango SP, et al. Expert review of the evidence base for arthropod bite avoidance. J Travel Med. 2010;17(3):182–92.

    Article  Google Scholar 

  • Hill DR, Baird JK, Parise ME, Lewis LS, et al. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg. 2006;75:402–15.

    Article  CAS  Google Scholar 

  • Krause G, Schöneberg I, Altmann D, Stark K. Chemoprophylaxis and malaria death rates. Emerg Infect Dis. 2006;12:447–51.

    Article  Google Scholar 

  • Lange WR, Frankenfield DL, Moriarty-Sheehan M, Contoreggi CS, Frame JD. No evidence for chloroquine-associated retinopathy among missionaries on long-term malaria chemoprophylaxis. Am J Trop Med Hyg. 1994;51(4):389–92.

    Article  CAS  Google Scholar 

  • Lachish T, Bar-Meir M, Eisenberg N, Schwartz E. Effectiveness of twice a week prophylaxis with atovaquone–proguanil (malarone) in long-term travellers to West Africa. J Travel Med. 2016;23(6):1–5.

    Article  Google Scholar 

  • Leder K, Torresi J, Libman MD, Cramer JP, et al. GeoSentinel surveillance of illness in returned travelers. Ann Intern Med. 2013;158:456–68.

    Article  Google Scholar 

  • Leder K, Black J, O’Brien D, Greenwood Z, et al. Malaria in travelers: a review of the GeoSentinel Surveillance Network. Clin Infect Dis. 2004;39:1104–12.

    Article  Google Scholar 

  • Lobel HO, Miani M, Eng T, Bernard KW, et al. Long-term malaria prophylaxis with weekly mefloquine. Lancet. 1993;341:848–51.

    Article  CAS  Google Scholar 

  • Luthi B, Schlagenhauf P. Risk factors associated with malaria deaths in travellers: a literature review. Travel Med Infect Dis. 2015;13(1):48–60.

    Article  Google Scholar 

  • McGready R, Ashley EA, Nosten F. Malaria and the pregnant traveller. Travel Med Infect Dis. 2004;2:127–42.

    Article  CAS  Google Scholar 

  • Murray CK, Gasser RA, Magill AJ, Miller RS. Update on rapid diagnostic testing for malaria. Clin Microbiol Rev. 2008;21(1):97–110.

    Article  Google Scholar 

  • Mueller I, Galinski MR, Baird JK, Carlton JM, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009;9(9):555–66.

    Article  CAS  Google Scholar 

  • Pavli A, Maltezou HC. Malaria and travellers visiting friends and relatives. Travel Med Infect Dis. 2010;8:161–8.

    Article  Google Scholar 

  • Robinson P, Jenney AW, Tachado M, Yung A, et al. Imported malaria treated in Melbourne, Australia: epidemiology and clinical features in 246 patients. J Travel Med. 2001;8:76–81.

    Article  CAS  Google Scholar 

  • Schlagenhauf P, Petersen E. Malaria chemoprophylaxis: strategies for risk groups. Clin Microbiol Rev. 2008;21(3):466–72.

    Article  Google Scholar 

  • Staines HM, Burrow R, Teo BH et al. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis. J Antimicrob Chemother. 2017. [Epub ahead of print].

    Google Scholar 

  • Stanczyk NM, Behrens RH, Chen-Hussey V, et al. Mosquito repellents for travellers. BMJ. 2015;350:h99.

    Article  Google Scholar 

  • Tan KR, Magill AJ, Parise ME, Arguin PM. Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg. 2011;84(4):517–31.

    Article  Google Scholar 

  • The Royal Children’s Hospital Melbourne. Insect repellents—guidelines for safe use. Updated May 2018. 2018. https://www.rch.org.au/kidsinfo/fact_sheets/Insect_repellents_guidelines_for_safe_use/. Accessed 11 July 2018.

  • Wittes R, Saginur R. Adverse reaction to mefloquine associated with ethanol ingestion. Can Med Assoc J. 1995;152:515–7.

    CAS  Google Scholar 

  • World Health Organization. WHO International Travel and Health. http://www.who.int/ith/en/; for country list <http://www.who.int/ith/ith-country-list.pdf>.

  • World Health Organization (WHO). World malaria report 2017. Geneva: World Health Organization. License: CC BY-NC-SA 3.0 IGO. http://www.who.int/malaria/publications/world-malaria-report-2017/report/en/. Accessed 11 July 2018.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Torresi, J. et al. (2019). Malaria Prevention. In: Manual of Travel Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-13-7252-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-7252-0_3

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-7251-3

  • Online ISBN: 978-981-13-7252-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics